News and analysis for those planning for or living in retirement
[ad_1] From MarketWatch Retirement: New Alzheimer’s drug shows some promise, but has big price tag. Lecanemab, which will be sold under the brand name Leqembi, will be priced at $26,500 per year. Leqembi has received a slightly warmer reception from the medical community than predecessor drug Aduhelm. What catch-up contribution? Congressional snafu leaves older retirement … Read more